113 related articles for article (PubMed ID: 9189231)
1. Chemotherapy for AIDS-related malignancies does not increase HIV viraemia.
Rutschmann OT; Pechère M; Krischer J; Perrin L; Hirschel B
AIDS; 1997 Jun; 11(7):944-5. PubMed ID: 9189231
[No Abstract] [Full Text] [Related]
2. Current approaches to the treatment of HIV-related Kaposi's sarcoma and lymphoma by chemotherapy.
Stewart JS
AIDS; 1990; 4 Suppl 1():S217-21. PubMed ID: 2152571
[No Abstract] [Full Text] [Related]
3. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
4. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
5. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
Palmieri C; Treibel T; Large O; Bower M
QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
[TBL] [Abstract][Full Text] [Related]
7. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer agents.
TreatmentUpdate; 1998 Jun; 10(4):1-6. PubMed ID: 11365440
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
10. Current therapy of HIV associated infections and malignancies.
Ratnam KV; Goh A
Singapore Med J; 1994 Jun; 35(3):298-302. PubMed ID: 7997909
[TBL] [Abstract][Full Text] [Related]
11. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
12. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
14. AIDS related malignant disease at regional institute of medical sciences.
Gatphoh ED; Zamzachin G; Devi SB; Punyabati P
Indian J Pathol Microbiol; 2001 Jan; 44(1):1-4. PubMed ID: 12561985
[TBL] [Abstract][Full Text] [Related]
15. Effects on virological and immunological parameters during CD34 mobilization in HIV patients with lymphoma.
Bortolin MT; Simonelli C; Zanussi S; Pratesi C; Bidoli E; Rupolo M; Berretta M; Tedeschi R; De Paoli P
Am J Hematol; 2006 Oct; 81(10):800-2. PubMed ID: 16838324
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
[TBL] [Abstract][Full Text] [Related]
17. [Intestinal diseases in HIV infection].
Münch R
Praxis (Bern 1994); 1997 Jul; 86(29-30):1151-3. PubMed ID: 9333912
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy for Kaposi sarcoma associated with acquired immunodeficiency syndrome: still a valid treatment option?
Rouanet I; Lechiche C; Doncesco R; Mauboussin JM; Sotto A
AIDS Patient Care STDS; 2013 Oct; 27(10):537-8. PubMed ID: 24050760
[No Abstract] [Full Text] [Related]
19. [Antineoplastic chemotherapy in patients with HIV infection].
Spina M; Tirelli U; Monfardini S
G Ital Chemioter; 1991; 38(1-3):79-82. PubMed ID: 1365618
[No Abstract] [Full Text] [Related]
20. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
